To our knowledge, our studies are the first to investigate the impact of endogenous germline p16 mutants on cell proliferation using fibroblasts from normal skin biopsies of individuals in familial melanoma/pancreatic cancer families. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.